Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer

Armando Bertuzzi, Maria Grazia Daidone, Giovanni Di Fronzo, Rosella Silvestrini

Research output: Contribution to journalArticle

Abstract

Kinetic and estrogen receptor (ER) determinations were performed on 357 primary breast cancers. The proliferative activity of the cell population was determined by the autoradiographic technique and expressed as [3H]thymidine labeling index (LI); the ER status was assessed by the absorption charcoal technique. From the overall analysis of the relationship between proliferative activity and ER status, by using the median LI value as cutoff of low and high proliferating tumors, a correlation between ER + status and low proliferative activity and between ER-status and high proliferative activity was observed in 64% of the cases. Menopausal status proved to be an important determinant of kinetic and ER features. In fact, the proliferative activity was always higher in ER - tumors than in ER + tumors within the same menopausal group, and a decrease in proliferative activity was observed from premenopause to postmenopause within ER + and ER - tumors. The analysis of the relation between ER levels and proliferative activity in ER + tumors also evidenced three main ER/LI clusters significantly related to premenopause, paramenopause and postmenopause. A particular indication of nodal involvement was evidenced for a cluster of tumors with low ER levels and high LI from postmenopausal patients. The three different, previously proposed kinetic groups of potential relevance for prognostic and therapeutic purposes were confirmed and more precisely defined by considering not only premenopause and postmenopause but also paramenopause.

Original languageEnglish
Pages (from-to)253-262
Number of pages10
JournalBreast Cancer Research and Treatment
Volume1
Issue number3
DOIs
Publication statusPublished - Sep 1981

Fingerprint

Estrogen Receptors
Breast Neoplasms
Premenopause
Postmenopause
Neoplasms
Charcoal
Thymidine

Keywords

  • estrogen receptors
  • labeling index
  • menopausal status

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer. / Bertuzzi, Armando; Daidone, Maria Grazia; Fronzo, Giovanni Di; Silvestrini, Rosella.

In: Breast Cancer Research and Treatment, Vol. 1, No. 3, 09.1981, p. 253-262.

Research output: Contribution to journalArticle

Bertuzzi, Armando ; Daidone, Maria Grazia ; Fronzo, Giovanni Di ; Silvestrini, Rosella. / Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer. In: Breast Cancer Research and Treatment. 1981 ; Vol. 1, No. 3. pp. 253-262.
@article{86ad475e2be74d87962c4c4603994f7a,
title = "Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer",
abstract = "Kinetic and estrogen receptor (ER) determinations were performed on 357 primary breast cancers. The proliferative activity of the cell population was determined by the autoradiographic technique and expressed as [3H]thymidine labeling index (LI); the ER status was assessed by the absorption charcoal technique. From the overall analysis of the relationship between proliferative activity and ER status, by using the median LI value as cutoff of low and high proliferating tumors, a correlation between ER + status and low proliferative activity and between ER-status and high proliferative activity was observed in 64{\%} of the cases. Menopausal status proved to be an important determinant of kinetic and ER features. In fact, the proliferative activity was always higher in ER - tumors than in ER + tumors within the same menopausal group, and a decrease in proliferative activity was observed from premenopause to postmenopause within ER + and ER - tumors. The analysis of the relation between ER levels and proliferative activity in ER + tumors also evidenced three main ER/LI clusters significantly related to premenopause, paramenopause and postmenopause. A particular indication of nodal involvement was evidenced for a cluster of tumors with low ER levels and high LI from postmenopausal patients. The three different, previously proposed kinetic groups of potential relevance for prognostic and therapeutic purposes were confirmed and more precisely defined by considering not only premenopause and postmenopause but also paramenopause.",
keywords = "estrogen receptors, labeling index, menopausal status",
author = "Armando Bertuzzi and Daidone, {Maria Grazia} and Fronzo, {Giovanni Di} and Rosella Silvestrini",
year = "1981",
month = "9",
doi = "10.1007/BF01806265",
language = "English",
volume = "1",
pages = "253--262",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York LLC",
number = "3",

}

TY - JOUR

T1 - Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer

AU - Bertuzzi, Armando

AU - Daidone, Maria Grazia

AU - Fronzo, Giovanni Di

AU - Silvestrini, Rosella

PY - 1981/9

Y1 - 1981/9

N2 - Kinetic and estrogen receptor (ER) determinations were performed on 357 primary breast cancers. The proliferative activity of the cell population was determined by the autoradiographic technique and expressed as [3H]thymidine labeling index (LI); the ER status was assessed by the absorption charcoal technique. From the overall analysis of the relationship between proliferative activity and ER status, by using the median LI value as cutoff of low and high proliferating tumors, a correlation between ER + status and low proliferative activity and between ER-status and high proliferative activity was observed in 64% of the cases. Menopausal status proved to be an important determinant of kinetic and ER features. In fact, the proliferative activity was always higher in ER - tumors than in ER + tumors within the same menopausal group, and a decrease in proliferative activity was observed from premenopause to postmenopause within ER + and ER - tumors. The analysis of the relation between ER levels and proliferative activity in ER + tumors also evidenced three main ER/LI clusters significantly related to premenopause, paramenopause and postmenopause. A particular indication of nodal involvement was evidenced for a cluster of tumors with low ER levels and high LI from postmenopausal patients. The three different, previously proposed kinetic groups of potential relevance for prognostic and therapeutic purposes were confirmed and more precisely defined by considering not only premenopause and postmenopause but also paramenopause.

AB - Kinetic and estrogen receptor (ER) determinations were performed on 357 primary breast cancers. The proliferative activity of the cell population was determined by the autoradiographic technique and expressed as [3H]thymidine labeling index (LI); the ER status was assessed by the absorption charcoal technique. From the overall analysis of the relationship between proliferative activity and ER status, by using the median LI value as cutoff of low and high proliferating tumors, a correlation between ER + status and low proliferative activity and between ER-status and high proliferative activity was observed in 64% of the cases. Menopausal status proved to be an important determinant of kinetic and ER features. In fact, the proliferative activity was always higher in ER - tumors than in ER + tumors within the same menopausal group, and a decrease in proliferative activity was observed from premenopause to postmenopause within ER + and ER - tumors. The analysis of the relation between ER levels and proliferative activity in ER + tumors also evidenced three main ER/LI clusters significantly related to premenopause, paramenopause and postmenopause. A particular indication of nodal involvement was evidenced for a cluster of tumors with low ER levels and high LI from postmenopausal patients. The three different, previously proposed kinetic groups of potential relevance for prognostic and therapeutic purposes were confirmed and more precisely defined by considering not only premenopause and postmenopause but also paramenopause.

KW - estrogen receptors

KW - labeling index

KW - menopausal status

UR - http://www.scopus.com/inward/record.url?scp=0019863323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019863323&partnerID=8YFLogxK

U2 - 10.1007/BF01806265

DO - 10.1007/BF01806265

M3 - Article

C2 - 7348575

AN - SCOPUS:0019863323

VL - 1

SP - 253

EP - 262

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -